Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Linch

Showing results (121-130 of 129) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 129 results.
Blood|June 5, 2009
WT1 mutations in T-ALLValeria Tosello, Marc R Mansour, Kelly Barnes, et al.
Blood|February 23, 2023
Dual targeting of CD19 and CD22 with bicistronic CAR-T cells in patients with relapsed/refractory large B-cell lymphomaClaire Roddie, Lazaros J Lekakis, Maria A V Marzolini, et al.
Blood|January 6, 2019
Genomic landscape and clonal evolution of acute myeloid leukemia with t(8;21): an international study on 331 patientsFriederike Christen, Kaja Hoyer, Kenichi Yoshida, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 31, 2021
Durable Responses and Low Toxicity After Fast Off-Rate CD19 Chimeric Antigen Receptor-T Therapy in Adults With Relapsed or Refractory B-Cell Acute Lymphoblastic LeukemiaClaire Roddie, Juliana Dias, Maeve A O'Reilly, et al.
The Journal of Clinical Investigation|August 9, 2008
Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patientsSteven J Howe, Marc R Mansour, Kerstin Schwarzwaelder, et al.
Journal of Hematology & Oncology|August 19, 2024
Genomic characterization of AML with aberrations of chromosome 7: a multinational cohort of 519 patientsAdriane Halik, Marlon Tilgner, Patricia Silva, et al.
The New England Journal of Medicine|December 14, 2011
Adenovirus-associated virus vector-mediated gene transfer in hemophilia BAmit C Nathwani, Edward G D Tuddenham, Savita Rangarajan, et al.
Nature Cell Biology|October 27, 2014
Cyclin C is a haploinsufficient tumour suppressorNa Li, Anne Fassl, Joel Chick, et al.
Blood|January 29, 2026
Common variation at 1q23.3, 2p23.3, 2q33.3, and 2p21 influences risk of acute myeloid leukemiaDiyanath Ranasinghe, Wei-Yu Lin, Sarah E Fordham, et al.
Pageof 13

Showing results (121-130 of 129) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 129 results.
Blood|June 5, 2009
WT1 mutations in T-ALLValeria Tosello, Marc R Mansour, Kelly Barnes, et al.
Blood|February 23, 2023
Dual targeting of CD19 and CD22 with bicistronic CAR-T cells in patients with relapsed/refractory large B-cell lymphomaClaire Roddie, Lazaros J Lekakis, Maria A V Marzolini, et al.
Blood|January 6, 2019
Genomic landscape and clonal evolution of acute myeloid leukemia with t(8;21): an international study on 331 patientsFriederike Christen, Kaja Hoyer, Kenichi Yoshida, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 31, 2021
Durable Responses and Low Toxicity After Fast Off-Rate CD19 Chimeric Antigen Receptor-T Therapy in Adults With Relapsed or Refractory B-Cell Acute Lymphoblastic LeukemiaClaire Roddie, Juliana Dias, Maeve A O'Reilly, et al.
The Journal of Clinical Investigation|August 9, 2008
Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patientsSteven J Howe, Marc R Mansour, Kerstin Schwarzwaelder, et al.
Journal of Hematology & Oncology|August 19, 2024
Genomic characterization of AML with aberrations of chromosome 7: a multinational cohort of 519 patientsAdriane Halik, Marlon Tilgner, Patricia Silva, et al.
The New England Journal of Medicine|December 14, 2011
Adenovirus-associated virus vector-mediated gene transfer in hemophilia BAmit C Nathwani, Edward G D Tuddenham, Savita Rangarajan, et al.
Nature Cell Biology|October 27, 2014
Cyclin C is a haploinsufficient tumour suppressorNa Li, Anne Fassl, Joel Chick, et al.
Blood|January 29, 2026
Common variation at 1q23.3, 2p23.3, 2q33.3, and 2p21 influences risk of acute myeloid leukemiaDiyanath Ranasinghe, Wei-Yu Lin, Sarah E Fordham, et al.
Pageof 13